HLK Biotech Holding Group, Inc. (AMHD) 股票表現
查看HLK Biotech Holding Group, Inc.的財務表現,包括市值、價格變動百分比、本益比,以及歷史和當前股價。
前收盤價0.00
52週高點0.01
打開0.00
52週低點0.00
資金流向0.00%
本益比0%
T/O0.00b
市淨率0%
離職率0.00%
市值0.00b
股息0
總股數0.04b
股息殖利率0%
批量大小1
HLK Biotech Holding Group, Inc.公司簡介
HLK Biotec Holding Group through their subsidiary (Nanjing) Health
Food co., LTD. operate in Nanjing China. Established in September
2004 the company's registered capital is $10 million. The company
owns a GMP approved factory and produces Traditional Chinese
Medicine (TCM). The company possess a group of hightech
r&d
talents and a group of senior management marketing professionals
to establish a market centered
business operation mechanism. The
management mechanism of the escrowÃÂþ Peopleoriented
motivation
mechanismÃÂþ A productcentered
control mechanismÃÂþ The education
training system is continuously improved with customercentric
brand service mechanism, and the management of national market
and the development of new market are strengthened. The
Company uses a "Hailekang marketing model" (Franchise model), to
build a new commercial forms. With the support of satellite network
platform and the guidance of the new marketing idea, in the national
start Hailekang chain convenience store (satellite), through
"consumer selfemployment
selfemployment"
reflects true
consumption value to meet the needs of consumer terminal
consumers from all walks of life. The Company has interests in the
Hong Kong Hailekang Group International Investment co., LTD